GB202315017D0 - Powder for oral solution formulations - Google Patents

Powder for oral solution formulations

Info

Publication number
GB202315017D0
GB202315017D0 GBGB2315017.0A GB202315017A GB202315017D0 GB 202315017 D0 GB202315017 D0 GB 202315017D0 GB 202315017 A GB202315017 A GB 202315017A GB 202315017 D0 GB202315017 D0 GB 202315017D0
Authority
GB
United Kingdom
Prior art keywords
powder
oral solution
solution formulations
formulations
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2315017.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Approved Pharma Solutions Ltd
Custom Healthcare Ltd
Original Assignee
Approved Pharma Solutions Ltd
Custom Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Approved Pharma Solutions Ltd, Custom Healthcare Ltd filed Critical Approved Pharma Solutions Ltd
Priority to GBGB2315017.0A priority Critical patent/GB202315017D0/en
Publication of GB202315017D0 publication Critical patent/GB202315017D0/en
Pending legal-status Critical Current

Links

GBGB2315017.0A 2023-09-29 2023-09-29 Powder for oral solution formulations Pending GB202315017D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2315017.0A GB202315017D0 (en) 2023-09-29 2023-09-29 Powder for oral solution formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2315017.0A GB202315017D0 (en) 2023-09-29 2023-09-29 Powder for oral solution formulations

Publications (1)

Publication Number Publication Date
GB202315017D0 true GB202315017D0 (en) 2023-11-15

Family

ID=88696352

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2315017.0A Pending GB202315017D0 (en) 2023-09-29 2023-09-29 Powder for oral solution formulations

Country Status (1)

Country Link
GB (1) GB202315017D0 (en)

Similar Documents

Publication Publication Date Title
EP4087406A4 (en) Vesicle compositions for oral delivery
GB2592117B (en) Oral solution cannabinoid formulations
IL290472A (en) Oral pharmaceutical composition containing heterocyclic compound
IL292682A (en) Oral formulation of x842
EP4122483A4 (en) Oral pharmaceutical composition
IL283593A (en) Oral formulations of branaplam
SE546142C2 (en) New compositions for oral use
GB202315017D0 (en) Powder for oral solution formulations
EP4129413A4 (en) Composition for oral cavity
EP4041263A4 (en) Oral care composition comprising cuttlefish bone powder
GB2613211B (en) Alkaline oral formulations
GB202308845D0 (en) Fast release oral formulations i
GB202308846D0 (en) Fast release oral formulations ii
GB202311981D0 (en) Oral compositions
GB202307626D0 (en) Pharmaceutical formulations
IL312055A (en) Oral formulation
GB202406312D0 (en) Oral formulations comprising nicotine salt
CA225361S (en) Pouch for oral products
GB202312074D0 (en) Oral composition for perimenopause
GB202315863D0 (en) Formulations
GB202307059D0 (en) Formulations
GB202216961D0 (en) 5-meo-mt formulations
CA214434S (en) Oral vaporizer
GB202208809D0 (en) Nicotine formulations
GB202204171D0 (en) Novel formulations